Answers are grounded in this paper and cite their sources.
Using syngeneic murine tumor models established in immunocompetent hosts, we showed that cancer stem cells are immunogenic and can be selectively targeted by dendritic cell-based vaccines. This new approach induced both humoral and cellular immune responses and conferred significantly superior antitumor immunity as compared with conventional vaccines.
No takes yet. Share an insight, caveat, or question.
Teitz‐Tennenbaum et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: